StemSight is proud to join the EU-funded KeratOPrinter project, aimed at revolutionizing corneal transplantation. This groundbreaking initiative uses advanced bioprinting technology to create full-thickness, biocompatible corneas, addressing the global shortage of donor tissue.

The project is set to redefine corneal transplantation, making vision-restoring therapy more accessible, efficient, and sustainable. The collaborative effort, involving partners from five EU countries, promises to restore vision for millions.

Our CEO and founder Laura Koivusalo has been selected as one of the 6 semifinalists for the European Prize for Women Innovators in the Rising Innovators category. The Rising Innovators Prize celebrates exceptional women leaders under the age of 35. 

As an innovative technology company focused on creating lasting benefits to the European health ecosystem, StemSight is a prime candidate for EU's EIC Accelerator funding. This highly competitive funding scheme requires two application phases, and a final interview. StemSight has been invited to the interview in front of an expert jury taking place in-person in Brussels in January 2025! 

Europe's premier partnering event will be held in Stockholm on 4-6 November. StemSight has been selected as one of the 8 companies to pitch in the Startup Sportlight session in front of a panel of expert judges.  Our CEO Laura Koivusalo will be on stage and available for partnering at the event.